EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokoll

Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial

Nils Inge Landrø, Catherine J Harmer, Simon E Blackwell, Ragnhild Bø, Gerry Dawson, Guy Goodwin, Hallvard Solbø Hagen, Jonathan Kingslake, Atle Klovning, Ole Klungsøyr, Olivia Schjøtt-Pedersen, Anne Kjersti Sæther und 4 weitere

Contemporary Clinical Trials · 2023

DOI: 10.1016/j.cct.2023.107326 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2023. Verfasst von Nils Inge Landrø und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Norway. Electronic address: n.i.landro@psykologi.uio.no. Hauptthemen laut MEDLINE: Antidepressive Agents, Major Depressive Disorder, Attentional Bias, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Major depressive disorder (MDD) is a highly prevalent psychiatric condition associated with significant disability, mortality and economic burden. A large proportion of MDD patients are treated in primary health care in the local community. Attentional Bias Modification (ABM) training in combination with antidepressants could be an effective treatment. Here we test the hypothesis that adding an ABM procedure to regular treatment with antidepressants in primary health care will result in further improvement of symptoms compared to treatment with antidepressants alone (treatment as usual, TAU) and as compared to an active comparison condition. METHODS: A total of 246 patients with a diagnosis of MDD will be included in this study. The study is a three-armed pragmatic randomized controlled trial comparing the efficacy of ABM as add-on to treatment with antidepressants in primary care (ABM condition) compared to standard antidepressant treatment (TAU condition). In a third group participants will complete the same schedule of intermediate assessments as the ABM condition in addition to TAU, but no ABM, thus controlling for the non-training-specific aspects of the ABM condition (Antidepressant active comparison group). DISCUSSION: The clinical outcome of this study may help develop easily accessible, low-cost treatment of depression in primary health care. Moreover, the study aims to broaden our knowledge of optimal treatment for patients with a MDD by providing adjunct treatment to facilitate recovery and long-term gain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsMajor Depressive DisorderAttentional BiasCognitive Behavioral TherapyHumansPrimary Health CarePragmatic Clinical Trials as TopicMaleFemaleCombined Modality TherapyAdultMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

AntidepressantsAttention Bias modificationMajor depressive disorderPragmatic randomized controlled trialPrimary health care

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Norway. Electronic address: n.i.landro@psykologi.uio.no.
  • Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Norway; Department of Psychiatry, Oxford University, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK.
  • Mental Health Research and Treatment Centre, Department of Psychology, Ruhr-Universität Bochum, Germany.
  • Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Norway.
  • P1vital Ltd Wallingford, UK.
  • Compass Pathways, UK.

Förderung

  • Norges Forskningsråd

Zitieren

APA

Landrø, N. I., Harmer, C. J., Blackwell, S. E., Bø, R., Dawson, G., Goodwin, G., Hagen, H. S., Kingslake, J., Klovning, A., Klungsøyr, O., Schjøtt-Pedersen, O., Sæther, A. K., Torgersen, K. S., Vaaler, A., Andreassen, O. A., & Røssberg, J. I. (2023). Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2023.107326

Vancouver

Landrø NI, Harmer CJ, Blackwell SE, Bø R, Dawson G, Goodwin G, et al. Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial. Contemporary Clinical Trials. 2023. doi:10.1016/j.cct.2023.107326

BibTeX
@article{Landr2023,
  author = {Landrø, Nils Inge and Harmer, Catherine J and Blackwell, Simon E and Bø, Ragnhild and Dawson, Gerry and Goodwin, Guy and Hagen, Hallvard Solbø and Kingslake, Jonathan and Klovning, Atle and Klungsøyr, Ole and Schjøtt-Pedersen, Olivia and Sæther, Anne Kjersti and Torgersen, Kristin Stensland and Vaaler, Arne and Andreassen, Ole A and Røssberg, Jan Ivar},
  title = {Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial},
  journal = {Contemporary Clinical Trials},
  year = {2023},
  doi = {10.1016/j.cct.2023.107326}
}
Kostenlos starten →